Home > Insider Trading > Filing (0001014108-17-000199)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1337013	Infusystem Holdings Inc	INFU	Surgical & Medical Instruments & Apparatus (3841)	203341405

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1519525	R. Christopher Sansone	C/O Infusystem Holdings, Inc. 31700 Research Park Drive Madison Heights MI 48071		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-28	33,008	$2.30	1,310,012	No	4	P	Direct
Common Stock	Acquisiton	2017-11-28	8,252	$2.30	276,138	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,483,548	Indirect	See
Common Stock	1,483,548	Indirect	See
Common Stock	1,483,548	Indirect	See

Footnotes

The reported securities are directly owned by Sansone Partners, L.P.
The reported securities are directly owned by Sansone Partners (QP), L.P.
The reported securities are directly owned by (i) Sansone Partners, L.P., a Delaware limited partnership (the "3c1 Partnership"), and (ii) Sansone Partners (QP), L.P., a Delaware limited partnership (the "3c7 Partnership", and together with 3c1 Partnership, the "Partnerships"), and may be deemed to be indirectly beneficially owned by Sansone Advisors, LLC, a Delaware limited liability company, as the investment manager of Partnerships (the "Investment Manager"), and by Sansone Capital Management, LLC, a Delaware limited liability company, as the general partner of the Partnerships (the "General Partner"). The reported securities may also be deemed to be indirectly beneficially owned by Christopher Sansone as the managing member of the Investment Manager and the General Partner. The reporting persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein.